Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT07573228
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- Exercise training — OTHER15 weeks of HIIT exercise training
Study Details
The purpose of this study is: * To see if insulin resistance (how sensitive your muscle tissue is to insulin) is associated with lower cardio fitness in people with Type 1 diabetes compared to healthy controls, before and after a High Intensity Interval Training (HIIT) exercise program. * To see if being overweight and having Type 1 diabetes is associated with lower cardio fitness compared to overweight healthy controls, before and after a HIIT exercise program.
Key Dates
- Start date
- Feb 23, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Type 1 diabetes - normal weightType 1 diabetes normal weight
- Active Comparator: Control - normal weighthealthy control - normal weight
- Active Comparator: Overweight controlOverweight, otherwise healthy
- Active Comparator: Type 1 diabetes - overweightType 1 diabetes - overweight
Primary Outcome Measure
Microvascular blood volume in skeletal and cardiac muscle - changes from baseline [ Time Frame: Before and after 15 weeks of exercise training ]
Central Contacts
- Lee Hartline, MEd434-924-5247
- Zhenqi Liu, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22908 | Zhenqi Liu, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
By condition
By specialty
By research site
Related Studies
- Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 DiabetesRecruiting · University of Virginia · Charlottesville, Virginia
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightPHASE2 · Recruiting · Eli Lilly and Company · Chandler, Arizona
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back PainPHASE3 · Recruiting · Eli Lilly and Company · Chandler, Arizona
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityPHASE3 · Recruiting · Amgen · Daphne, Alabama